167 related articles for article (PubMed ID: 31913076)
1. Comparison of Cancer Specific Outcomes following Minimally Invasive and Open Surgical Resection of Early Stage Kidney Cancer from a National Cancer Registry.
Auffenberg GB; Curry M; Gennarelli R; Blum KA; Elkin E; Russo P
J Urol; 2020 Jun; 203(6):1094-1100. PubMed ID: 31913076
[TBL] [Abstract][Full Text] [Related]
2. Impact of Perioperative Infection on Cancer Specific Survival after Nephrectomy for Renal Cell Carcinoma.
Tallman JE; Pearce SM; Kuchta K; Helfand BT; Eggener SE
J Urol; 2017 Nov; 198(5):1027-1032. PubMed ID: 28551443
[TBL] [Abstract][Full Text] [Related]
3. Minimally invasive vs open nephrectomy in the modern era: does approach matter?
Golombos DM; Chughtai B; Trinh QD; Thomas D; Mao J; Te A; O'Malley P; Scherr DS; Del Pizzo J; Hu JC; Sedrakyan A
World J Urol; 2017 Oct; 35(10):1557-1568. PubMed ID: 28477204
[TBL] [Abstract][Full Text] [Related]
4. Oncological outcomes of minimally invasive partial versus minimally invasive radical nephrectomy for cT1-2/N0/M0 clear cell renal cell carcinoma: a propensity score-matched analysis.
Simone G; Tuderti G; Anceschi U; Papalia R; Ferriero M; Misuraca L; Minisola F; Mastroianni R; Costantini M; Guaglianone S; Sentinelli S; Gallucci M
World J Urol; 2017 May; 35(5):789-794. PubMed ID: 27578234
[TBL] [Abstract][Full Text] [Related]
5. Long-term survival following partial vs radical nephrectomy among older patients with early-stage kidney cancer.
Tan HJ; Norton EC; Ye Z; Hafez KS; Gore JL; Miller DC
JAMA; 2012 Apr; 307(15):1629-35. PubMed ID: 22511691
[TBL] [Abstract][Full Text] [Related]
6. Renal cell carcinoma in octogenarians: nephron sparing surgery should remain the standard of care.
Hellenthal NJ; Mansour AM; Hayn MH; Schwaab T
J Urol; 2011 Feb; 185(2):415-20. PubMed ID: 21167523
[TBL] [Abstract][Full Text] [Related]
7. Renal cell carcinoma in the solitary kidney: an analysis of complications and outcome after nephron sparing surgery.
Ghavamian R; Cheville JC; Lohse CM; Weaver AL; Zincke H; Blute ML
J Urol; 2002 Aug; 168(2):454-9. PubMed ID: 12131287
[TBL] [Abstract][Full Text] [Related]
8. Does partial nephrectomy result in a durable overall survival benefit in the Medicare population?
Smaldone MC; Egleston B; Uzzo RG; Kutikov A
J Urol; 2012 Dec; 188(6):2089-94. PubMed ID: 23083877
[TBL] [Abstract][Full Text] [Related]
9. Comparative Effectiveness of Thermal Ablation, Surgical Resection, and Active Surveillance for T1a Renal Cell Carcinoma: A Surveillance, Epidemiology, and End Results (SEER)-Medicare-linked Population Study.
Xing M; Kokabi N; Zhang D; Ludwig JM; Kim HS
Radiology; 2018 Jul; 288(1):81-90. PubMed ID: 29737950
[TBL] [Abstract][Full Text] [Related]
10. National Norwegian Practice Patterns for Surgical Treatment of Kidney Cancer Tumors ≤7cm: Adherence to Changes in Guidelines May Improve Overall Survival.
Hjelle KM; Johannesen TB; Bostad L; Reisæter LAR; Beisland C
Eur Urol Oncol; 2018 Aug; 1(3):252-261. PubMed ID: 31102628
[TBL] [Abstract][Full Text] [Related]
11. Management of Small Kidney Cancers in the New Millennium: Contemporary Trends and Outcomes in a Population-Based Cohort.
Huang WC; Atoria CL; Bjurlin M; Pinheiro LC; Russo P; Lowrance WT; Elkin EB
JAMA Surg; 2015 Jul; 150(7):664-72. PubMed ID: 26017316
[TBL] [Abstract][Full Text] [Related]
12. 10-year oncologic outcomes after laparoscopic and open partial nephrectomy.
Lane BR; Campbell SC; Gill IS
J Urol; 2013 Jul; 190(1):44-9. PubMed ID: 23306087
[TBL] [Abstract][Full Text] [Related]
13. Systematic review and meta-analysis of thermal ablation versus surgical nephrectomy for small renal tumours.
Katsanos K; Mailli L; Krokidis M; McGrath A; Sabharwal T; Adam A
Cardiovasc Intervent Radiol; 2014 Apr; 37(2):427-37. PubMed ID: 24482030
[TBL] [Abstract][Full Text] [Related]
14. [Minimally invasive vs. open partial nephrectomy : Perioperative success and complication rates].
Boy A; Hein J; Bollow M; Lazica D; Roosen A; Ubrig B
Urologe A; 2018 Jul; 57(7):821-827. PubMed ID: 29691592
[TBL] [Abstract][Full Text] [Related]
15. Survival after partial and radical nephrectomy for the treatment of stage T1bN0M0 renal cell carcinoma (RCC) in the USA: a propensity scoring approach.
Badalato GM; Kates M; Wisnivesky JP; Choudhury AR; McKiernan JM
BJU Int; 2012 May; 109(10):1457-62. PubMed ID: 21933334
[TBL] [Abstract][Full Text] [Related]
16. Assessment of survival of patients with metastatic clear cell renal cell carcinoma after radical cytoreductive nephrectomy versus no surgery: a seer analysis.
Xiao WJ; Zhu Y; Dai B; Zhang HL; Ye DW
Int Braz J Urol; 2015; 41(2):288-95. PubMed ID: 26005970
[TBL] [Abstract][Full Text] [Related]
17. Evolving trends in the surgical management of renal masses over the past two decades: A contemporary picture from a large prospectively-maintained database.
Chen K; Lee A; Huang HH; Tay KJ; Sim A; Lee LS; Cheng CWS; Ng LG; Ho HSS; Yuen JSP
Int J Urol; 2019 Apr; 26(4):465-474. PubMed ID: 30818418
[TBL] [Abstract][Full Text] [Related]
18. A comparison of overall survival and perioperative outcomes between partial and radical nephrectomy for cT1b and cT2 renal cell carcinoma-Analysis of a national cancer registry.
Venkatramani V; Koru-Sengul T; Miao F; Nahar B; Prakash NS; Swain S; Punnen S; Ritch C; Gonzalgo M; Parekh D
Urol Oncol; 2018 Mar; 36(3):90.e9-90.e14. PubMed ID: 29254672
[TBL] [Abstract][Full Text] [Related]
19. Prediction of Complications Following Partial Nephrectomy: Implications for Ablative Techniques Candidates.
Larcher A; Fossati N; Tian Z; Boehm K; Meskawi M; Valdivieso R; Trudeau V; Dell'Oglio P; Buffi N; Montorsi F; Guazzoni G; Sun M; Karakiewicz PI
Eur Urol; 2016 Apr; 69(4):676-682. PubMed ID: 26206408
[TBL] [Abstract][Full Text] [Related]
20. A non-cancer-related survival benefit is associated with partial nephrectomy.
Sun M; Trinh QD; Bianchi M; Hansen J; Hanna N; Abdollah F; Shariat SF; Briganti A; Montorsi F; Perrotte P; Karakiewicz PI
Eur Urol; 2012 Apr; 61(4):725-31. PubMed ID: 22172373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]